Skip to main content

Table 9 Comparison between study groups as regards ICU mortality

From: A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

Time Group A Group B A/B#
Death 19 (60.0%) 26 (80.0%) 0.168
  1. #Chi-square test